Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor

By Meden H.   Kuhn W.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 71, Iss. 2, 1997-02 ,pp. : 173-179

Elsevier

Access to resources Recommend Favorite

Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer

By Nijman H.W.   Kenemans P.   Poort-Keesom R.J.J.   Verstraeten R.A.   Mensdorff-Pouilly S.   Verheijen R.H.M.   Melief C.J.M.   Hilgers J.   Meijer C.J.L.M.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 83, Iss. 2, 1999-04 ,pp. : 201-206

Elsevier

Access to resources Recommend Favorite

Bacterial vaginosis diagnosed at the first antenatal visit better predicts preterm labour than diagnosis later in pregnancy

By Schoeman J.   Steyn P.   Odendaal H.   Grové D.  

Journal of Obstetrics & Gynaecology, Vol. 25, Iss. 8, 2005-11 ,pp. : 751-753

Informa Healthcare

Access to resources Recommend Favorite

The combination of p53 and age predict cancer specific death in advanced stage (FIGO Ic-IV) of endometrial carcinoma of endometrioid type An immunohistochemical examination of growth fraction: Ki-67, MIB-1 and PC10; suppressor oncogene protein: p53; oncogene protein: p185 and age, hormone treatment, stage, and histologic grade

By Nielsen A.L.   Nyholm H.C.J.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 70, Iss. 1, 1996-12 ,pp. : 79-85

Elsevier

Access to resources Recommend Favorite

Endometrial cancer and recurrence with hormonal manipulation

By Ghosh P   Fawzi H  

Journal of Obstetrics & Gynaecology, Vol. 24, Iss. 2, 2004-02 ,pp. : 192-193

Informa Healthcare

Access to resources Recommend Favorite